These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 7542477

  • 1. Stimulation by alkylxanthines of chloride efflux in CFPAC-1 cells does not involve A1 adenosine receptors.
    Jacobson KA, Guay-Broder C, van Galen PJ, Gallo-Rodriguez C, Melman N, Jacobson MA, Eidelman O, Pollard HB.
    Biochemistry; 1995 Jul 18; 34(28):9088-94. PubMed ID: 7542477
    [Abstract] [Full Text] [Related]

  • 2. A1 receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine selectively activates chloride efflux from human epithelial and mouse fibroblast cell lines expressing the cystic fibrosis transmembrane regulator delta F508 mutation.
    Guay-Broder C, Jacobson KA, Barnoy S, Cabantchik ZI, Guggino WB, Zeitlin PL, Turner RJ, Vergara L, Eidelman O, Pollard HB.
    Biochemistry; 1995 Jul 18; 34(28):9079-87. PubMed ID: 7542476
    [Abstract] [Full Text] [Related]

  • 3. A1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells.
    Eidelman O, Guay-Broder C, van Galen PJ, Jacobson KA, Fox C, Turner RJ, Cabantchik ZI, Pollard HB.
    Proc Natl Acad Sci U S A; 1992 Jun 15; 89(12):5562-6. PubMed ID: 1376923
    [Abstract] [Full Text] [Related]

  • 4. CPX, a selective A1-adenosine-receptor antagonist, regulates intracellular pH in cystic fibrosis cells.
    Casavola V, Turner RJ, Guay-Broder C, Jacobson KA, Eidelman O, Pollard HB.
    Am J Physiol; 1995 Jul 15; 269(1 Pt 1):C226-33. PubMed ID: 7543243
    [Abstract] [Full Text] [Related]

  • 5. 8-cyclopentyl-1,3-dipropylxanthine and other xanthines differentially bind to the wild-type and delta F508 first nucleotide binding fold (NBF-1) domains of the cystic fibrosis transmembrane conductance regulator.
    Cohen BE, Lee G, Jacobson KA, Kim YC, Huang Z, Sorscher EJ, Pollard HB.
    Biochemistry; 1997 May 27; 36(21):6455-61. PubMed ID: 9174362
    [Abstract] [Full Text] [Related]

  • 6. Purinoceptor activation of chloride transport in cystic fibrosis and CFTR-transfected pancreatic cell lines.
    O'Reilly CM, O'Farrell AM, Ryan MP.
    Br J Pharmacol; 1998 Aug 27; 124(8):1597-606. PubMed ID: 9756374
    [Abstract] [Full Text] [Related]

  • 7. Direct activation of cystic fibrosis transmembrane conductance regulator channels by 8-cyclopentyl-1,3-dipropylxanthine (CPX) and 1,3-diallyl-8-cyclohexylxanthine (DAX).
    Arispe N, Ma J, Jacobson KA, Pollard HB.
    J Biol Chem; 1998 Mar 06; 273(10):5727-34. PubMed ID: 9488705
    [Abstract] [Full Text] [Related]

  • 8. Stimulation of chloride secretion by P1 purinoceptor agonists in cystic fibrosis phenotype airway epithelial cell line CFPEo-.
    Chao AC, Zifferblatt JB, Wagner JA, Dong YJ, Gruenert DC, Gardner P.
    Br J Pharmacol; 1994 May 06; 112(1):169-75. PubMed ID: 8032638
    [Abstract] [Full Text] [Related]

  • 9. Activation of deltaF508 CFTR in a cystic fibrosis respiratory epithelial cell line by 4-phenylbutyrate, genistein and CPX.
    Andersson C, Roomans GM.
    Eur Respir J; 2000 May 06; 15(5):937-41. PubMed ID: 10853862
    [Abstract] [Full Text] [Related]

  • 10. Adenosine receptors in rat and human pancreatic ducts stimulate chloride transport.
    Novak I, Hede SE, Hansen MR.
    Pflugers Arch; 2008 May 06; 456(2):437-47. PubMed ID: 18057956
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists.
    Jacobson KA, Gallo-Rodriguez C, Melman N, Fischer B, Maillard M, van Bergen A, van Galen PJ, Karton Y.
    J Med Chem; 1993 May 14; 36(10):1333-42. PubMed ID: 8496902
    [Abstract] [Full Text] [Related]

  • 12. 1,3-Dipropyl-8-[2-(5,6-epoxy)norbornyl]xanthine, a potent, specific and selective A1 adenosine receptor antagonist in the guinea pig heart and brain and in DDT1MF-2 cells.
    Belardinelli L, Shryock JC, Zhang Y, Scammells PJ, Olsson R, Dennis D, Milner P, Pfister J, Baker SP.
    J Pharmacol Exp Ther; 1995 Dec 14; 275(3):1167-76. PubMed ID: 8531078
    [Abstract] [Full Text] [Related]

  • 13. No evidence for direct activation of the cystic fibrosis transmembrane conductance regulator by 8-cyclopentyl-1,3-dipropylxanthine.
    Kunzelmann K, Briel M, Schreiber R, Ricken S, Nitschke R, Greger R.
    Cell Physiol Biochem; 1998 Dec 14; 8(4):185-93. PubMed ID: 9694345
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
    Kim SA, Marshall MA, Melman N, Kim HS, Müller CE, Linden J, Jacobson KA.
    J Med Chem; 2002 May 23; 45(11):2131-8. PubMed ID: 12014951
    [Abstract] [Full Text] [Related]

  • 15. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
    Hayallah AM, Sandoval-Ramírez J, Reith U, Schobert U, Preiss B, Schumacher B, Daly JW, Müller CE.
    J Med Chem; 2002 Mar 28; 45(7):1500-10. PubMed ID: 11906291
    [Abstract] [Full Text] [Related]

  • 16. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
    Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB, Lohse MJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan 28; 357(1):1-9. PubMed ID: 9459566
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and structure-activity relationships of deazaxanthines: analogs of potent A1- and A2-adenosine receptor antagonists.
    Grahner B, Winiwarter S, Lanzner W, Müller CE.
    J Med Chem; 1994 May 13; 37(10):1526-34. PubMed ID: 8182711
    [Abstract] [Full Text] [Related]

  • 18. Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors.
    Kim YC, Ji X, Melman N, Linden J, Jacobson KA.
    J Med Chem; 2000 Mar 23; 43(6):1165-72. PubMed ID: 10737749
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bronchospasmolytic activity and adenosine receptor binding of some newer 1,3-dipropyl-8-phenyl substituted xanthine derivatives.
    Gumber D, Yadav D, Yadav R, Kachler S, Klotz KN.
    Chem Biol Drug Des; 2020 Jun 23; 95(6):600-609. PubMed ID: 32100461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.